MoneyWorks4Me

Biocon informs about company statement

16 Jul 2026 Evaluate
Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Malaysia Receives EMA Approval for New Drug Product Fill Finish Unit for Insulins’. The above information will also be available on the website of the Company at www.biocon.com. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..